Mind Medicine Inc (STU:MMQ)
€ 7.33 -0.12 (-1.61%) Market Cap: 518.05 Mil Enterprise Value: 296.28 Mil PE Ratio: 0 PB Ratio: 2.81 GF Score: 38/100

Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 17, 2023 / 08:35PM GMT
Release Date Price: €2.78 (-1.21%)
Brian Abrahams
RBC Capital Markets - Analyst

Okay. Good afternoon, everyone. I'm Brian Abrahams, one of the senior biotech analysts here at RBC Capital Markets. Our last presenting company of the day is MindMed represented by their CEO, Rob Barrow. Rob, thanks so much for joining us.

Rob Barrow;MindMed;Inc.;CEO
Mind Medicine

()-

Thank you.

Brian Abrahams
RBC Capital Markets - Analyst

So let's start bigger picture. The psychedelic field has received a significant amount of interest lately. What drives your approach at MindMed and where do you see yourself as being most differentiated? And I'm thinking with respect to your asset itself, the indication, and indications you're going to be looking at, and your administration of such?

Questions & Answers

Rob Barrow;MindMed;Inc.;CEO
Mind Medicine

()-

Yeah, absolutely. I've had the good fortune of working with a number of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot